Another study showed that Circ-RAPGEF5 was lowly expressed in renal cell carcinoma and exerted cancer-inhibiting effects in RCC via the miR-27a-3p/TXNIP pathway [37]. This evidence concerns the gene RAPGEF5 and cancer.